Stock listing

NASDAQ:PRME Prime Medicine, Inc. Stock

Home listing (NASDAQ) of Prime Medicine, Inc.

Follow Prime Medicine, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:PRME

$4.19 USD -0.08 (-1.9%)

Close on Nov 16, 2026

Past year +9.7% · daily closes, Nov 17, 2025 – Nov 16, 2026, adjusted for splits
Day range
$4.10 – $4.36 USDNov 16, 2026
Volume
6.74M sharesNov 16, 2026
Market cap
$760.0M USDAt the close on Nov 16, 2026 · price × 181.4M shares outstanding
52-week range
$2.67 – $5.91 USDLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
Traded on an average day
$17.40M USDMedian day 3.68M shares · last 3 months, Aug 17, 2026 – Nov 16, 2026
Prime Medicine, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PRME · Home$4.19 USD-0.08 (-1.9%)6,735,460$4.12$4.36$4.10$4.27Close on Nov 16, 2026

Daily closes

Last 3 months, Aug 17, 2026 – Nov 16, 2026 · NASDAQ:PRME · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$4.19-0.08-1.9%$4.12$4.36$4.106,735,460
$4.27+0.38+9.8%$4.05$4.426$4.015,953,488
$3.89-0.41-9.5%$4.04$4.13$3.737,167,410
$4.30+0.40+10.3%$3.93$4.35$3.8012,842,890
$3.90-0.40-9.3%$4.19$4.225$3.774,502,102
$4.30-0.35-7.5%$4.70$4.70$4.223,477,932
$4.65+0.20+4.5%$4.53$4.695$4.4553,058,654
$4.45-0.52-10.5%$4.86$4.91$4.3014,737,120
$4.97+0.42+9.2%$4.75$5.12$4.594,394,906
$4.55+0.11+2.5%$4.50$4.885$4.4354,115,219
$4.44-0.28-5.9%$4.74$4.84$4.3614,122,637
$4.72-0.52-9.9%$5.03$5.20$4.6756,556,079
$5.24-0.12-2.2%$5.21$5.91$5.1910,327,326
$5.36+1.01+23.2%$4.245$5.43$4.1115,165,766
$4.35+0.74+20.5%$3.62$4.41$3.578,810,312
$3.61-0.06-1.6%$3.66$3.70$3.572,508,756
$3.67-0.06-1.6%$3.70$3.70$3.384,560,300
$3.73-0.08-2.1%$3.68$3.92$3.624,657,500
$3.81-0.11-2.8%$3.92$4.005$3.7952,436,400
$3.92+0.09+2.3%$3.75$4.05$3.733,694,600
$3.83+0.36+10.4%$3.56$3.87$3.494,250,500
$3.47-0.14-3.9%$3.55$3.605$3.414,386,000
$3.61+0.48+15.3%$3.12$3.65$3.066,299,900
$3.13-0.19-5.7%$3.21$3.22$3.0454,236,500
$3.32-0.29-8.0%$3.61$3.61$3.274,058,100
$3.61-0.38-9.5%$3.95$3.965$3.583,132,900
$3.99+0.41+11.5%$3.57$4.14$3.548,064,200
$3.58-0.32-8.2%$3.83$3.898$3.527,721,200
$3.90+0.40+11.4%$3.36$4.02$3.3011,194,100
$3.50+0.29+9.0%$3.56$3.718$3.2612,014,000
$3.21+0.23+7.7%$3.00$3.26$2.884,716,900
$2.98-0.01-0.3%$3.05$3.075$2.922,108,600
$2.99-0.065-2.1%$3.05$3.105$2.982,825,800
$3.055-0.035-1.1%$3.11$3.19$3.023,126,900
$3.09+0.215+7.5%$2.93$3.135$2.883,605,600
$2.875-0.025-0.9%$2.85$2.92$2.773,681,400
$2.90-0.17-5.5%$3.42$3.44$2.8757,116,300
$3.07-0.06-1.9%$3.11$3.13$2.994,485,400
$3.13-0.41-11.6%$3.53$3.53$3.123,331,900
$3.54+0.35+11.0%$3.22$3.565$3.202,717,700
$3.19+0.07+2.2%$3.19$3.27$3.102,946,300
$3.12-0.02-0.6%$3.13$3.17$3.0454,672,500
$3.14+0.14+4.7%$3.11$3.39$3.103,252,700
$3.00-0.14-4.5%$3.18$3.22$2.933,290,400
$3.14-0.04-1.3%$3.18$3.22$3.002,573,100
$3.18+0.05+1.6%$3.10$3.28$3.101,616,200
$3.13-0.22-6.6%$3.38$3.44$3.103,075,700
$3.35-0.12-3.5%$3.37$3.42$3.312,386,300
$3.47-0.09-2.5%$3.47$3.535$3.294,223,300
$3.56-0.14-3.8%$3.65$3.65$3.413,600,800
$3.70-0.01-0.3%$3.83$3.86$3.651,618,700
$3.71+0.04+1.1%$3.70$3.72$3.492,311,700
$3.67+0.10+2.8%$3.50$3.705$3.472,473,900
$3.57-0.02-0.6%$3.54$3.71$3.482,453,000
$3.59-0.02-0.6%$3.54$3.635$3.462,092,600
$3.61-0.03-0.8%$3.57$3.70$3.482,693,500
$3.64+0.06+1.7%$3.55$3.665$3.481,832,800
$3.58-0.13-3.5%$3.66$3.66$3.4351,950,200
$3.71+0.46+14.2%$3.30$3.71$3.2853,320,951
$3.25-0.14-4.1%$3.38$3.40$3.1952,267,579
$3.39+0.15+4.6%$3.26$3.49$3.243,597,000
$3.24-0.30-8.5%$3.43$3.50$3.203,797,900
$3.54+0.49+16.1%$3.29$3.59$3.256,791,300
$3.05-0.12-3.8%$3.10$3.199$3.021,271,000
$3.17+0.08+2.6%$3.07$3.19$3.0211,500,700
Ticker
NASDAQ:PRME
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Prime Medicine (NASDAQ:PRME) Q3 2026 Earnings Call

    Mon, Nov 16, 2026 · 4:00 PM ET

    Watch Transcript

Latest news

All Prime Medicine, Inc. news

Financings

  • Public offering of common stock

    Nov 12, 2026

    Closed: US$143.7M raised · US$3.5 a share · Jefferies +4

    Dealers: Jefferies (co-lead), TD Cowen (co-lead), Goldman Sachs & Co. LLC (co-lead), Oppenheimer & Co., LifeSci Capital

    Use of proceeds: Strengthen the balance sheet and advance its programs through key clinical milestones

    Announced Nov 10, 2026 · Announced Nov 11, 2026 · Closed Nov 12, 2026

  • Public offering of common stock

    Aug 1, 2025

    Closed: US$144.2M raised · US$3.3 a share · TD Cowen +1

    Dealers: TD Cowen (co-lead), BMO Capital Markets (co-lead)

    Buyers: Cystic Fibrosis Foundation (1,818,181 shares of common stock)

    Announced Jul 30, 2025 · Announced Jul 31, 2025 · Closed Aug 1, 2025

  • Strategic investment of equity investment

    Jul 16, 2025

    Announced: US$6M

    Buyers: Cystic Fibrosis Foundation ($6 million equity investment in the first tranche of up to $24 million in funding)

    Use of proceeds: Accelerate development of Prime Editors to permanently correct cystic fibrosis-related lung disease

    Announced Jul 16, 2025

Read by 6ix AI from the company's releases

Decks

Prime Medicine, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 39 in all · newest Nov 12, 2026 · oldest 2024
Calls
1 call with a replay · 1 with a transcript · latest Nov 16, 2026
Decks
21 decks · latest Nov 10, 2026

Where Prime Medicine, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:PRME · Home listing · This pageNASDAQUnited StatesUSD
BOATS:PRMEBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Prime Medicine, Inc.